Royal Emerald Pharmaceuticals has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of controlled substances, specifically Marihuana (Cannabis), at their location in Desert Hot Springs, California. They intend to produce this substance to supply botanical raw materials and active pharmaceutical ingredients to researchers and manufacturers registered with the DEA. Individuals who wish to comment on or object to this application may do so electronically by May 27, 2025, through the Federal eRulemaking Portal. Written requests for a hearing regarding the application are also due by the same date.
Simple Explanation
Royal Emerald Pharmaceuticals wants to make special plant-based medicines, and they're asking for permission to do this from a big group called the DEA. People can tell the DEA what they think about this by sending a message before the end of May 2025.